Drug intelligence / Profile preview

CarbSlim

Development stage
Unknown
Lead developer
HealthAid
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

CarbSlim is a dietary supplement designed for weight management and carbohydrate control, primarily marketed by HealthAid. Its active ingredient is white kidney bean extract (*Phaseolus vulgaris*), often utilizing the proprietary Phase 2 Carb Controller formulation. The supplement functions as a carbohydrate blocker by inhibiting the enzyme alpha-amylase in the digestive tract. Alpha-amylase is responsible for the breakdown of complex starches into simple, absorbable sugars; by blocking this process, CarbSlim reduces the caloric absorption from starchy foods and may assist in weight loss and glycemic control. It is typically administered orally in capsule form and is categorized as a nutraceutical rather than a pharmaceutical drug.

Brand names
CarboSlimHealthAid CarboSlimCarboSlim Phase 2
Other names
White kidney bean extractPhaseolaminPhase 2 Carb ControllerPhase2 Carb ControllerPhase-2 Carb Controller
02

Targets

AMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on CarbSlim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CarbSlim.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call